Annals of vascular surgery · 2013
First experience of a novel femorocrural expanded polytetrafluoroethylene bypass graft.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tuijp Steven J, Flu Hans C, Donker Jeroen M W, Veen Eelco J, Ho Gwan H, de Groot Hans G, van der Waal Jan C, van der Laan Lyckle
Аннотация
BACKGROUND: This study aims to evaluate early results of a precuffed expanded polytetrafluoroethylene (ePTFE) Distaflo® Mini-Cuff Bypass Graft versus autologous saphenous vein (ASV) grafting in patients with peripheral arterial obstructive disease (PAOD).
METHODS: This retrospective single-center study analyzed 42 patients who received a femorocrural bypass graft because of PAOD using an ASV graft (n = 28) or Distaflo Mini-Cuff graft (n = 14).
RESULTS: Primary patency rates in the ASV and Distaflo Mini-Cuff groups were 81% and 69%, respectively, after 6 months. Secondary patency rates were 81% and 35%, respectively, after 12 months. The limb salvage rate was 81% in the ASV group vs 65% and 35%, respectively, in the Distaflo Mini-Cuff group after 6 months and 1 year.
CONCLUSIONS: The ePTFE Distaflo Mini-Cuff is an option for revascularization in the absence of a suitable ASV. However, the performance of this novel graft is not better than that of current ePTFE bypass grafts.
METHODS: This retrospective single-center study analyzed 42 patients who received a femorocrural bypass graft because of PAOD using an ASV graft (n = 28) or Distaflo Mini-Cuff graft (n = 14).
RESULTS: Primary patency rates in the ASV and Distaflo Mini-Cuff groups were 81% and 69%, respectively, after 6 months. Secondary patency rates were 81% and 35%, respectively, after 12 months. The limb salvage rate was 81% in the ASV group vs 65% and 35%, respectively, in the Distaflo Mini-Cuff group after 6 months and 1 year.
CONCLUSIONS: The ePTFE Distaflo Mini-Cuff is an option for revascularization in the absence of a suitable ASV. However, the performance of this novel graft is not better than that of current ePTFE bypass grafts.
Предметные рубрики MeSH
AgedAged, 80 and overAutograftsBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationConstriction, PathologicFemaleFemoral ArteryHumansLimb SalvageMaleMiddle AgedNetherlandsPeripheral Arterial DiseasePolytetrafluoroethyleneProsthesis DesignRetrospective StudiesSaphenous VeinTime FactorsTreatment OutcomeVascular Patency